Back to Journals » Breast Cancer: Targets and Therapy » Volume 3

Eribulin (Halaven): a new, effective treatment for women with heavily pretreated metastatic breast cancer

Total article views   HTML views PDF downloads Totals
20,890 Dovepress* 11,582+ 3,636 15,218
PubMed Central* 9,308 493 9,801
Totals 20,890 4,129 25,019
*Since 26 August 2011
+Since July 2016

View citations on PubMed Central and Google Scholar